Accelerating Delivery of Radiopharmaceutical Trials

Radiopharmaceutical trials are gaining traction across oncology and other therapeutic areas— but challenges remain in delivery, access, and scalability. In this expert-led webinar, leaders in clinical research, regulatory strategy, operational execution, and patient advocacy will explore how to de-risk and accelerate these programs through integrated planning and patient-focused design.

You’ll hear directly from experts who have helped sponsors navigate the complexities of radiopharmaceutical development—from aligning nuclear medicine and oncology teams to designing inclusive trials and enabling access beyond academic hubs. You’ll also hear from an oncology patient who participated in a radiopharmaceutical clinical trial, sharing his journey and perspective on what drives patient engagement.

What You’ll Learn

• How to connect nuclear medicine and oncology teams in early planning
• Regulatory and licensing strategies that support scalable trial delivery
• Considerations for site readiness, training, and cross-specialty coordination
• Approaches to improve patient access and geographic reach
• First-hand insights from a patient participant on navigating a radiopharmaceutical clinical trial
• Operational insights from leaders in clinical and strategic delivery

Speakers

• Dr. Mwango Kashoki, Senior Vice President, Global Head of Regulatory Strategy, Parexel
• Dr. Gwyn Bebb, MD, BM, BCh, PhD, Franchise Head, Oncology, Parexel
• Dr. Michael A. Morse, MD, FACP, MHS, Professor of Medicine and Surgery, Duke University School of Medicine
• Owen Lewis, Radiopharmaceutical Trial Patient